2-hydroxybenzylbenzimidazole has been researched along with Coxsackie Virus Infections in 1 studies
2-hydroxybenzylbenzimidazole: RN given refers to cpd without isomeric designation
| Excerpt | Relevance | Reference |
|---|---|---|
| "When guanidine was reduced to 48 mg/kg per injection, 34 mg/kg per injection of LY122771-72 was required to produce a significant reduction in the death rate and no tremors were observed." | 1.26 | Prevention of death in mice infected with coxsackievirus A16 using guanidine HCl mixed with substituted benzimidazoles. ( Delong, DC; Herrmann, EC; Herrmann, JA, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Herrmann, EC | 1 |
| Herrmann, JA | 1 |
| Delong, DC | 1 |
1 other study available for 2-hydroxybenzylbenzimidazole and Coxsackie Virus Infections
| Article | Year |
|---|---|
Prevention of death in mice infected with coxsackievirus A16 using guanidine HCl mixed with substituted benzimidazoles.
Topics: Animals; Antiviral Agents; Benzimidazoles; Coxsackievirus Infections; Drug Combinations; Drug Synerg | 1982 |